Mabion S.A. (FRA:272)
Germany · Delayed Price · Currency is EUR 1.734
+0.012 (0.70%)
At close: Nov 28, 2025
Mabion Company Description
Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
It offers drug substance manufacturing, fill and finish, gene to vial end-to-end development, process development, analytics, and banking services.
In addition, it offers cell line development, process development, production of a product for preclinical and clinical trials, development and validation of analytical methods, and preparation of the necessary documentation.
The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.
Mabion S.A.
| Country | Poland |
| Founded | 2007 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 213 |
| CEO | Krzysztof Kaczmarczyk |
Contact Details
Address: Medical Biotechnology Scientific and Industrial Complex Konstantynów Lódzki, 95-050 Poland | |
| Phone | 48 42 207 7890 |
| Website | mabion.eu |
Stock Details
| Ticker Symbol | 272 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Krzysztof Kaczmarczyk | Chief Executive Officer |
| Grzegorz Grabowicz | Chief Financial Officer |
| Julita Balcerek | Chief Operating Officer |